{
    "Title": "Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil",
    "URL": "https://doi.org/10.1371/journal.pntd.0007695",
    "Published": "September 17, 2019",
    "Subject_Areas": [
        "Zika fever",
        "Sphingolipids",
        "Antibodies",
        "Enzyme-linked immunoassays",
        "Chikungunya infection",
        "Glycolipids",
        "Guillain-Barre syndrome",
        "Arboviral infections"
    ],
    "Authors": {
        "Juan Rivera-Correa": [
            "New York University School of Medicine, Dept. of Microbiology, New York, New York, United States of America"
        ],
        "Isadora Cristina de Siqueira": [
            "Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador, Brazil"
        ],
        "Sabrina Mota": [
            "New York University School of Medicine, Dept. of Microbiology, New York, New York, United States of America"
        ],
        "Mateus Santana do Rosário": [
            "Hospital Santa Izabel, Salvador, Brazil"
        ],
        "Pedro Antônio Pereira de Jesus": [
            "Hospital Geral Roberto Santos, Secretaria Estadual da Saúde da Bahia, Salvador, Brazil"
        ],
        "Luiz Carlos Junior Alcantara": [
            "Laboratório de Flavivírus—Instituto Oswaldo Cruz—Fundação Oswaldo Cruz, Rio de Janeiro, Brazil"
        ],
        "Joel D. Ernst": [
            "New York University School of Medicine, Dept. of Microbiology, New York, New York, United States of America",
            "Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, United States of America"
        ],
        "Ana Rodriguez": [
            "New York University School of Medicine, Dept. of Microbiology, New York, New York, United States of America"
        ]
    }
}